Rich Pharmaceuticals, Inc. filed its 10-K on Sep 17, 2015 for the period ending Mar 31, 2015. In this report its auditor, KLJ & Associates, LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Rich Pharmaceuticals, Inc.
Equities
RCHA
US76303T4076
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.47% | 16.37B | |
+2.23% | 13.58B | |
+27.13% | 11.66B |